Evidence for a suppression of apoptosis in early postnatal life

Acta Obstet Gynecol Scand. 2001 Nov;80(11):994-7. doi: 10.1034/j.1600-0412.2001.801104.x.

Abstract

Background: In fetal life the rates of proliferation and apoptosis are high. We studied if the rate of apoptosis decreases after birth, by measuring the soluble (s) forms of Fas-Fas ligand and Tumor necrosis factor receptor 1 (TNFR1)-TNF-alpha which attenuate apoptosis.

Subjects and methods: Blood was drawn from the umbilical cord and from a peripheral vein on day 1 and 4 of life in 35 infants and sFas, sFas ligand, sTNFR1 and sTNF-alpha were determined by enzyme immunoassays. Data were analyzed by paired t-test and Pearson's correlation analysis.

Results: sFas and sTNF increased significantly from birth to day 4 of life (p=0.033 and p<0.0001 respectively), while sTNFR1 increased significantly from birth to day 1 of life (p<0.0001) followed by a significant decrease on day 4 of life (p<0.0001). The levels of sFas and sTNF-alpha on day 1 correlated with those on day 4 (r=0.677, p<0.0002 and r=0.525, p<0.007 respectively). sFAS ligand was not detectable in any specimen.

Conclusion: The increasing concentrations of the soluble molecules, sFas, sTNF-alpha and sTNFR1 might indicate that apoptosis may be downregulated in early postnatal life.

MeSH terms

  • Apoptosis / physiology*
  • Down-Regulation / physiology*
  • Fas Ligand Protein
  • Female
  • Fetal Blood / chemistry
  • Humans
  • Infant, Newborn / blood
  • Infant, Newborn / physiology*
  • Male
  • Membrane Glycoproteins / blood
  • Pregnancy
  • Receptors, Tumor Necrosis Factor / blood
  • Tumor Necrosis Factor-alpha / metabolism
  • fas Receptor / blood

Substances

  • FASLG protein, human
  • Fas Ligand Protein
  • Membrane Glycoproteins
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • fas Receptor